omni
aaps
High-Throughput Flow Cytometry And Phenotypic Drug Discovery
High-Throughput Flow Cytometry And Phenotypic Drug Discovery
Researchers from the Genomics Institute of the Novartis Research Foundation (GNF) highlight a diversity of approaches that their automated high-throughput flow cytometry has enabled for phenotypic drug discovery.
How Might Biopharma Manufacturing Differ In The Next Decade?
How Might Biopharma Manufacturing Differ In The Next Decade?
When embarking on our pulling together the manufacturing outlook article for our December 2017 issue, we faced what many might describe as a good problem to have - too much content and not enough pages.
Could This Drug Help the Brain Recover After a Stroke?
Could This Drug Help the Brain Recover After a Stroke?
Despite years of effort, researchers have so far failed to find a pill you could take or a food you could eat to harden your brain against the injury that could be caused by a stroke.
New Efforts Taking Root to Ease Off-Label Drug Promotion
New Efforts Taking Root to Ease Off-Label Drug Promotion
Legislative campaigns to ease restrictions on the off-label promotion of medicines could put patients' health at risk and leave them paying for costly drugs for which there is little evidence in support of their use, researchers said in a recent article.
NIH Abruptly Changes Course On Industry Opioids Partnership After Ethics Flags Raised
NIH Abruptly Changes Course On Industry Opioids Partnership After Ethics Flags Raised
It's been touted by health officials for almost a year: a planned opioids research partnership worth roughly $400 million.
Why Pharma Strategic Planning Reduces Productivity And How To Fix It
Why Pharma Strategic Planning Reduces Productivity And How To Fix It
As is often the case in pharma, Emma Walmsley, the CEO of Glaxo, soon after taking office announced a reorganization of R&D, no doubt the product of a thoughtful strategic plan.
The Why, How And When Of AI In The Pharmaceutical Industry
The Why, How And When Of AI In The Pharmaceutical Industry
Recently, pharmaceutical companies have been demonstrating a vivid interest in artificial intelligence (AI) applications for various research needs, catalyzed by the illustrative practical achievements of AI in solving more "traditional" tasks - overco...
FDA Prepping for Push of New Gene and Cell Therapies
FDA Prepping for Push of New Gene and Cell Therapies
In addition to new draft guidance documents on gene therapy-related issues, the U.S. Food and Drug Administration (FDA) will also release guidance on the clinical development of gene and cell therapies, FDA Commissioner Scott Gottlieb said at the Allia...
President Trump's Plan to Lower Drug Prices Spares Pharma Industry
President Trump's Plan to Lower Drug Prices Spares Pharma Industry
President Donald Trump's long-promised plan to bring down drug prices would mostly spare the pharmaceutical industry he previously accused of "getting away with murder." Instead he focuses on private competition and more openness to reduce America's pr...
Cloud Pharmaceuticals Enters Into Drug Discovery Collaboration With GSK
Cloud Pharmaceuticals Enters Into Drug Discovery Collaboration With GSK
Cloud Pharmaceuticals, Inc., an Artificial Intelligence-driven drug design and development company, announced they have entered into drug discovery collaboration with GlaxoSmithKline (GSK). Cloud will design novel small-molecule agents to GSK specified...
Scientists Develop New Method To Make Drugs Smarter
Scientists Develop New Method To Make Drugs Smarter
Scientists from the University of Lincoln in the U.K. have created a new technique using nanotechnology which can make drugs more effective at reaching their target.
AI in Medicine Gets Closer To Making Regular Rounds
AI in Medicine Gets Closer To Making Regular Rounds
The Food and Drug Administration recently approved a software algorithm that helps doctors identify hand fractures in X-rays.
Pharma And Biotech Leaders Back 'No Deal' Brexit Warning
Pharma And Biotech Leaders Back 'No Deal' Brexit Warning
A cross-party committee of MPs has urged the Government to secure a post-Brexit deal with Europe to protect patients and the UK's pharma and biotech sectors.
These New Pharma Bros Are Wreaking Havoc on Prescription Drug Prices
These New Pharma Bros Are Wreaking Havoc on Prescription Drug Prices
For at least the past three years, Todd Smith and Benjamin Bove have crisscrossed the U.S., offering a sure-fire fix for struggling pharmaceutical companies. And wherever they go, the price of prescription drugs tends to skyrocket.